Announcement PDF WHERE BIOTECHNOLOGY & NANOTECHNOLGY MEET IMAGION BIOSYSTEMS LIMITED (ASX: IBX) To: Australian Securities Exchange Limited Filed by: Imagion Biosystems Limited Ref: Alyn Tai Tel: (03) 8622 3352 Notice Pursuant to Section 708A(5)(e) of the Corporations Act Imagion Biosystems Limited (the Company) gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) as follows: (a) On 28 November 2018, the Company issued 98,159,510 fully paid ordinary shares in the Company. (b) The shares were issued without disclosure to the recipients under Part 6D.2 of the Corporations Act. (c) As at the date of this notice the Company has complied with: (d) ▪ the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and ▪ Section 674 of the Corporations Act. As at the date of this notice there is no excluded information required to be disclosed under section 708A(6)(e) of the Corporations Act. Dated: 28 November 2018 Signed for Imagion Biosystems Limited Jovanka Naumoska Company Secretary Imagion Biosystems Limited ACN 616 305 027 Level 8, 555 Bourke Street, Melbourne VIC 3000 www.imagionbiosystems.com